Makker V - Search Results

1

A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.

Rezk YA, Hurley KE, Carter J, Dao F, Bochner BH, Aubey JJ, Caceres A, Einstein MH, Abu-Rustum NR, Barakat RR, Makker V, Chi DS. Rezk YA, et al. Among authors: makker v. Gynecol Oncol. 2013 Feb;128(2):191-7. doi: 10.1016/j.ygyno.2012.09.030. Epub 2012 Oct 9. Gynecol Oncol. 2013. PMID: 23063761 Free PMC article.

2

Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146.

Makker V, Taylor MH, Aghajanian C, Cohn AL, Brose MS, Simone CD, Cao ZA, Suttner L, Loboda A, Cristescu R, Jelinic P, Orlowski R, Dutta L, Matsui J, Dutcus CE, Minoshima Y, Messing MJ. Makker V, et al. J Immunother Cancer. 2024 Jan 19;12(1):e007929. doi: 10.1136/jitc-2023-007929. J Immunother Cancer. 2024. PMID: 38242717 Free PMC article.

3

Current Evidence-Based Systemic Therapy for Advanced and Recurrent Endometrial Cancer.

Gordhandas S, Zammarrelli WA, Rios-Doria EV, Green AK, Makker V. Gordhandas S, et al. Among authors: makker v. J Natl Compr Canc Netw. 2023 Feb;21(2):217-226. doi: 10.6004/jnccn.2022.7254. J Natl Compr Canc Netw. 2023. PMID: 36791759 Free PMC article. Review.

4

Characterization and Management of Adverse Reactions in Patients With Advanced Endometrial Cancer Receiving Lenvatinib Plus Pembrolizumab.

Colombo N, Lorusso D, Monk BJ, Slomovitz B, Hasegawa K, Nogueira-Rodrigues A, Zale M, Okpara CE, Barresi G, McKenzie J, Makker V. Colombo N, et al. Among authors: makker v. Oncologist. 2024 Jan 5;29(1):25-35. doi: 10.1093/oncolo/oyad201. Oncologist. 2024. PMID: 37523661 Free PMC article.

5

Decreased HER2 expression in endometrial cancer following anti-HER2 therapy.

Chui MH, Brown DN, Da Cruz Paula A, da Silva EM, Momeni-Boroujeni A, Reis-Filho JS, Zhang Y, Makker V, Ellenson LH, Weigelt B. Chui MH, et al. Among authors: makker v. J Pathol. 2024 Feb;262(2):129-136. doi: 10.1002/path.6230. Epub 2023 Nov 27. J Pathol. 2024. PMID: 38013631

6

Body mass index and adiposity influence responses to immune checkpoint inhibition in endometrial cancer.

Gómez-Banoy N, Ortiz E, Jiang CS, Dagher C, Sevilla C, Girshman J, Pagano A, Plodkowski A, Zammarrelli WA, Mueller JJ, Aghajanian C, Weigelt B, Makker V, Cohen P, Osorio JC. Gómez-Banoy N, et al. Among authors: makker v. medRxiv [Preprint]. 2024 Jun 9:2024.06.07.24308618. doi: 10.1101/2024.06.07.24308618. medRxiv. 2024. Update in: J Clin Invest. 2024 Jun 20;134(17):e180516. doi: 10.1172/JCI180516 PMID: 38883775 Free PMC article. Updated. Preprint.

7

A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.

Makker V, Abu-Rustum NR, Alektiar KM, Aghajanian CA, Zhou Q, Iasonos A, Hensley ML. Makker V, et al. Gynecol Oncol. 2008 Nov;111(2):249-54. doi: 10.1016/j.ygyno.2008.06.035. Epub 2008 Aug 27. Gynecol Oncol. 2008. PMID: 18755503 Free PMC article.

8

Concurrent carboplatin/paclitaxel and intravaginal radiation in surgical stage I-II serous endometrial cancer.

Alektiar KM, Makker V, Abu-Rustum NR, Soslow RA, Chi DS, Barakat RR, Aghajanian CA. Alektiar KM, et al. Among authors: makker v. Gynecol Oncol. 2009 Jan;112(1):142-5. doi: 10.1016/j.ygyno.2008.10.006. Epub 2008 Nov 20. Gynecol Oncol. 2009. PMID: 19019418 Free PMC article.

9

Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer.

Kiess AP, Damast S, Makker V, Kollmeier MA, Gardner GJ, Aghajanian C, Abu-Rustum NR, Barakat RR, Alektiar KM. Kiess AP, et al. Among authors: makker v. Gynecol Oncol. 2012 Nov;127(2):321-5. doi: 10.1016/j.ygyno.2012.07.112. Epub 2012 Jul 28. Gynecol Oncol. 2012. PMID: 22850412

10

Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.

Folkert MR, Shih KK, Abu-Rustum NR, Jewell E, Kollmeier MA, Makker V, Barakat RR, Alektiar KM. Folkert MR, et al. Among authors: makker v. Gynecol Oncol. 2013 Feb;128(2):288-93. doi: 10.1016/j.ygyno.2012.11.012. Epub 2012 Nov 15. Gynecol Oncol. 2013. PMID: 23159818

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters